Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
“The articles in this issue’s Cornea section focus on challenging situations in cornea and the tools that we have to address them,” said Cornea Editor Julie Schallhorn, MD. She expressed her frustration with the current healthcare environment in meeting the needs of these more challenging patients.
Opacified corneas can present an additional challenge when preparing a patient for cataract surgery. Three physicians discussed how they handle these patients and specific considerations.
BrightMEM corneal allograft (Brightstar Therapeutics) is a new treatment option for ocular surface disease. Several sources discussed BrightMEM, their experience using it, and its treatment applications.
ASCRS Subspecialty Day will take place on Friday, April 25, ahead of the official kickoff of the main 2025 ASCRS Annual Meeting. This year, attendees can expect exciting programs focusing on refractive, cornea, and glaucoma topics. The program chairs discussed what they’re looking forward to.
This year, the Richard L. Lindstrom, MD, Lecture will be given by Reza Dana, MD, during the Main Stage session on Sunday, April 27, at the ASCRS Annual Meeting. Dr. Dana said the lecture will focus on his research in the field of cornea.
➤ NDA submitted to the FDA for presbyopia drop ➤ FDA issues complete response letter to dry eye NDA ➤ FDA accepts BLA resubmission for bevacizumab to treat wet AMD ➤ One-month results in Phase 1/2 trial for treating Leber congenital amaurosis in a pediatric patient ➤ ASCRS news and events
➤ Long-term data on treatment for neuropathic corneal pain ➤ European agency issues positive opinion for low-dose atropine formulation ➤ Study: semaglutide use associated with increased risk of NAION ➤ Company news ➤ ASCRS news and events
➤ Voluntary IOL recall ➤ Phase 4 study assesses patient-reported outcomes of dry eye drop ➤ Study: synthetic opsin restores vision in cases of severe retinal degeneration ➤ Phase 3 endpoints not met in trial evaluating wet AMD treatment ➤ Merger news ➤ ASCRS news and events
➤ FDA accepts new drug application for pharmaceutical aiming to treat pediatric myopia ➤ FDA approves treatment for macular telangiectasia type 2 ➤ Survey reveals perspectives of patients with glaucoma ➤ New wearable vision testing platform ➤ Seeking Fast Track Designation for investigational treatment of neuropathic corneal pain ➤ Fast Track Designation granted to gene therapy targeting X-linked retinoschisis ➤ ASCRS news and events
➤ Proof-of-concept trial for intravitreal implant for glaucoma patients ➤ Phase 3 study evaluating intravitreal gene therapy for wet AMD ➤ New analysis shows differentiation of investigational glaucoma treatment ➤ IND studies to investigate gene therapy for dry AMD ➤ ASCRS news and events